Agios Pharmaceuticals (AGIO) Enterprise Value (2013 - 2026)
Agios Pharmaceuticals (AGIO) reported Enterprise Value of $1.59 billion for Q2 2026, up 60.8% from $991.42 million a year earlier and up 25.5% from the prior quarter.
Agios Pharmaceuticals (AGIO) Enterprise Value (2013 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, Agios Pharmaceuticals' Enterprise Value came in at -$949.96 million; for FY2025, it came in at $736.55 million, down 25.2% from FY2024.
- Enterprise Value has a five-year compound annual growth rate of -21.2% (FY2020 to FY2025).
- By year, Enterprise Value came in at $984.45 million in FY2024 (+109.9%), $468.97 million in FY2023 (-38.5%), $762.4 million in FY2022 (-0.5%) and $765.95 million in FY2021 (-68.5%).
- The Q2 2026 figure ranks as the highest quarterly Enterprise Value since Q2 2024.
- Year over year, Enterprise Value gained in four of the last eight quarters, with growth averaging 28.8%.
- The high point for year-over-year Enterprise Value in five years was Q2 2023 (growth of 121.2%); the low point was Q2 2022 (a decline of 75.7%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $1.27 billion (Q1 2026), $736.55 million (Q4 2025) and $1.39 billion (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.97 Bn | 1,105.55 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 619.72 Bn | 538.25 Bn | 17.26 Bn |
| 3 | AbbVie | 503.40 Bn | 476.52 Bn | 12.70 Bn |
| 4 | Merck | 370.15 Bn | 324.53 Bn | 12.21 Bn |
| 5 | Novartis Ag | 298.64 Bn | 262.63 Bn | 11.24 Bn |
| 6 | Astrazeneca | 261.07 Bn | 234.76 Bn | 12.86 Bn |
| 7 | Amgen | 237.00 Bn | 192.40 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 191.24 Bn | 165.43 Bn | 6.22 Bn |
| 9 | Pfizer | 170.31 Bn | 116.96 Bn | 10.94 Bn |
| 10 | Agios Pharmaceuticals | 2.22 Bn | -943.26 Mn | 41.75 Mn |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.59 Bn |
| Mar 31, 2026 | 1.27 Bn |
| Dec 31, 2025 | 736.55 Mn |
| Sep 30, 2025 | 1.39 Bn |
| Jun 30, 2025 | 991.42 Mn |
| Mar 31, 2025 | 802.71 Mn |
| Dec 31, 2024 | 984.45 Mn |
| Sep 30, 2024 | 1.53 Bn |
| Jun 30, 2024 | 1.88 Bn |
| Mar 31, 2024 | 1.06 Bn |
| Dec 31, 2023 | 468.97 Mn |
| Sep 30, 2023 | 735.64 Mn |
| Jun 30, 2023 | 875.84 Mn |
| Mar 31, 2023 | 536.58 Mn |
| Dec 31, 2022 | 762.40 Mn |
| Sep 30, 2022 | 824.72 Mn |
| Jun 30, 2022 | 395.95 Mn |
| Mar 31, 2022 | 671.01 Mn |
| Dec 31, 2021 | 765.95 Mn |
| Sep 30, 2021 | 1.26 Bn |
Agios Pharmaceuticals Enterprise Value API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=enterprise-value&ticker=AGIO&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "enterprise-value", "ticker": "AGIO", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=enterprise-value&ticker=AGIO&period=max&api_key=YOUR_API_KEY");
const data = await res.json();